Martin Bussmann
Director/Board Member bei PARAMOUNT GROUP, INC.
Vermögen: 175 837 $ am 31.03.2024
Profil
Martin Bussmann is currently the Managing Director & Director at Mannheim Holdings LLC, Lead Independent Director at Paramount Group, Inc., and Director at Mannheim Real Estate LLC.
Previously, he worked as a Director at Pelikan Technologies, Inc. and Cellwar Holding AG, Principal at Abbott Laboratories and Knoll AG, Manager at Margna Holding SA, Trustee at The Mannheim Trust, President at Rhodanie Investment AG, and Trustee at Marico Trust (New York).
He holds a graduate degree and a doctorate from Ruprecht-Karls-Universität Heidelberg.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Paramount Group Operating Partnership LP
0,22% | 01.03.2023 | 37 492 ( 0,22% ) | 175 837 $ | 31.03.2024 |
Aktive Positionen von Martin Bussmann
| Unternehmen | Position | Beginn |
|---|---|---|
| PARAMOUNT GROUP, INC. | Director/Board Member | 24.03.2016 |
Mannheim Holdings LLC
 Mannheim Holdings LLC Financial ConglomeratesFinance Mannheim Holdings LLC is an investment holding private company. The company is based in New York, NY. The CEO of the company is Martin Bussmann. | Chief Executive Officer | - |
| Mannheim Real Estate LLC | Director/Board Member | - |
Ehemalige bekannte Positionen von Martin Bussmann
| Unternehmen | Position | Ende |
|---|---|---|
| Marico Trust (New York) | Director/Board Member | 01.01.2005 |
| Margna Holding SA | Corporate Officer/Principal | 01.01.1998 |
Rhodanie Investment AG
 Rhodanie Investment AG Financial ConglomeratesFinance Rhodanie Investment AG provides investment services. The private company is based in Munchenbuchsee, Switzerland. | President | - |
Cellwar Holding AG
 Cellwar Holding AG Financial ConglomeratesFinance Cellwar Holding AG functions as an investment holding Swiss company. The private company is based in Munchenbuchsee, Switzerland. | Director/Board Member | - |
| The Mannheim Trust | Director/Board Member | - |
Ausbildung von Martin Bussmann
| Ruprecht-Karls-Universität Heidelberg | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| PARAMOUNT GROUP, INC. | Finance |
| Private Unternehmen | 9 |
|---|---|
Pelikan Technologies, Inc.
 Pelikan Technologies, Inc. Medical SpecialtiesHealth Technology Pelikan Technologies, Inc. develops hand held diagnostic and monitoring devices. It combines novel and proprietary blood sampling and measurement techniques with state-of-the-art miniaturization and automation technologies to develop superior hand-held medical diagnostic and monitoring devices. The company was founded in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The private company is based in Haren, Germany. | Health Technology |
Mannheim Holdings LLC
Mannheim Holdings LLC Financial ConglomeratesFinance Mannheim Holdings LLC is an investment holding private company. The company is based in New York, NY. The CEO of the company is Martin Bussmann. | Finance |
| Margna Holding SA | |
| The Mannheim Trust | Miscellaneous |
Cellwar Holding AG
Cellwar Holding AG Financial ConglomeratesFinance Cellwar Holding AG functions as an investment holding Swiss company. The private company is based in Munchenbuchsee, Switzerland. | Finance |
Rhodanie Investment AG
Rhodanie Investment AG Financial ConglomeratesFinance Rhodanie Investment AG provides investment services. The private company is based in Munchenbuchsee, Switzerland. | Finance |
| Marico Trust (New York) | |
| Mannheim Real Estate LLC |
